Balaxi Pharmaceuticals
BALAXINSE

Balaxi Pharmaceuticals

₹21.122.32 (12.34%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
18.02
Today’s high
21.98
52 week low
15.20
52 week high
73.70
Open price
18.70
Previous close
18.80
Live volume
3,41,132
Lower circuit
16.90
Upper circuit
25.34

Fundamentals

Market Cap
₹117Cr
ROE
6.09%
P/E Ratio(TTM)
12.35
EPS(TTM)
1.71
P/B Ratio
0.49
Dividend Yield
0.00%
Industry P/E
31.31
Book Value
43.12
Debt to Equity
0.24
Face Value
2

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Balaxi Pharmaceuticals is a globally recognized company enhancing healthcare by providing a wide range of pharmaceuticals in the frontier markets of Latin America and Africa. Its vision is to establish strong product portfolios and channel networks, aiming to expand into 20 frontier markets over the next 5 years. The company's mission is to become a top pharmaceutical player in these markets, focusing on scale, healthy margins, and quality growth in a balanced way. Its diverse portfolio includes a well-balanced mix of generics and branded generics, with products like antibiotics, analgesics, and anti-malaria drugs. As part of its backward integration strategies, it is establishing a pharmaceutical formulation facility in Hyderabad, India to ensure quality and reduce dependency. The company has an impressive track record of 960 product registrations in multiple countries, with another 700 underway to expand its presence.;
MD/CEO
Mr. Ashish Maheshwari
Founded in
1942
NSE symbol
BALAXI
Industry

Shareholding Pattern

Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Promoters
65.99%
Retail And Others
32.24%
Foreign Institutions
1.74%
Other Domestic Institutions
0.02%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹704.40
+0.45 (0.06%)
L
    H
    4,025.7730.43.94
    ₹388.25
    -4.50 (1.15%)
    L
      H
      3,640.7240.624.99
      Aarti DrugsAARTIDRUGS
      ₹352.70
      +6.30 (1.82%)
      L
        H
        3,213.1615.872.19
        ₹288.60
        -0.10 (0.03%)
        L
          H
          2,905.6958.074.6
          2026
          28
          Jan
          Quarterly Result
          Release date
          2025
          11
          Nov
          Quarterly Result
          Release date
          5
          Aug
          Quarterly Result
          Release date
          2024

          30
          May
          Split
          Ex date
          2:10
          Ratio

          For each share you hold, you will receive 5 shares with face value of ₹2.0 each
          Split Ratio2:10
          Ex date30 May ‘24
          Record date30 May ‘24
          Announcement date28 Feb ‘24
          Events calendar
          View upcoming events in other stocks